Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile
Yale Hematology Oncology Fellows

@yalehemonc

Official Twitter of the @Yale Hematology & Oncology Fellowship Program
@YaleHematology | @YaleCancer | @SmilowCancer

ID: 1270450690008252416

linkhttps://medicine.yale.edu/intmed/education/fellowship/oncology/ calendar_today09-06-2020 20:20:38

717 Tweet

2,2K Followers

227 Following

Yale Cancer Center (@yalecancer) 's Twitter Profile Photo

On National #CancerSurvivorsDay, Tendai Kwaramba, MD. MSc. presents new research outlining the risk of second primary cancers in long-term cancer survivors to help guide survivorship care and surveillance. #ASCO25 Yale Hematology Oncology Fellows Smilow Cancer Hospital OncoAlert meetings.asco.org/abstracts-pres…

On National #CancerSurvivorsDay, <a href="/KwarambaT90/">Tendai Kwaramba, MD. MSc.</a> presents new research outlining the risk of second primary cancers in long-term cancer survivors to help guide survivorship care and surveillance. #ASCO25 <a href="/YaleHemOnc/">Yale Hematology Oncology Fellows</a> <a href="/SmilowCancer/">Smilow Cancer Hospital</a> <a href="/OncoAlert/">OncoAlert</a> 

meetings.asco.org/abstracts-pres…
Yale Cancer Center (@yalecancer) 's Twitter Profile Photo

.Curt Perry presents #ASCO25 on a novel RNA sequencing approach to identify a resistance mechanism enriched in neuroendocrine tumors #NET, merkle cell carcinoma #MCC, and small cell lung cancer #SCLC. Yale Hematology Oncology Fellows Smilow Cancer Hospital OncoAlert meetings.asco.org/2025-asco-annu…

.<a href="/curtperrymdphd/">Curt Perry</a> presents #ASCO25 on a novel RNA sequencing approach to identify a resistance mechanism enriched in neuroendocrine tumors #NET, merkle cell carcinoma #MCC, and small cell lung cancer #SCLC. <a href="/YaleHemOnc/">Yale Hematology Oncology Fellows</a> <a href="/SmilowCancer/">Smilow Cancer Hospital</a> <a href="/OncoAlert/">OncoAlert</a> 
meetings.asco.org/2025-asco-annu…
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

This morning Dr. Casasanta was commanding her audience presenting on "TP53 genomic alterations including targetable TP53 Y220C mutation in clinically advanced breast cancer" at #ASCO25. Former fellow and now breast attending Dr. Du is clearly impressed. Incredible job Nicole!

This morning Dr. Casasanta was commanding her audience presenting on "TP53 genomic alterations including targetable TP53 Y220C mutation in clinically advanced breast cancer" at #ASCO25. Former fellow and now breast attending Dr. Du is clearly impressed. Incredible job Nicole!
Yale Cancer Center (@yalecancer) 's Twitter Profile Photo

Research led by Nicole Casasanta, MD YaleBreastCancer assessed the TP53 Y220C mutation landscape in clinically advanced #breastcancer (CABC) and found it to be a relatively rare event in CABC. #ASCO25 OncoAlert Smilow Cancer Hospital Yale Hematology Oncology Fellows meetings.asco.org/abstracts-pres…

Research led by <a href="/ncasasanta/">Nicole Casasanta, MD</a> <a href="/YaleBreast/">YaleBreastCancer</a> assessed the TP53 Y220C mutation landscape in clinically advanced #breastcancer (CABC) and found it to be a relatively rare event in CABC. #ASCO25 <a href="/OncoAlert/">OncoAlert</a> <a href="/SmilowCancer/">Smilow Cancer Hospital</a> <a href="/YaleHemOnc/">Yale Hematology Oncology Fellows</a> meetings.asco.org/abstracts-pres…
Yale Cancer Center (@yalecancer) 's Twitter Profile Photo

.Philippos Apolinario Costa, MD shared results of a phase 2 trial using Olaparib in IDH1 and IDH2 mutant #chondrosarcomas. Olaparib did not demonstrate activity, emphasizing the urgent need for additional therapeutic options. #ASCO25 OncoAlert Smilow Cancer Hospital Yale Hematology Oncology Fellows meetings.asco.org/abstracts-pres…

.<a href="/CostaPhilippos/">Philippos Apolinario Costa, MD</a> shared results of a phase 2 trial using Olaparib in IDH1 and IDH2 mutant #chondrosarcomas. Olaparib did not demonstrate activity, emphasizing the urgent need for additional therapeutic options. #ASCO25 <a href="/OncoAlert/">OncoAlert</a> <a href="/SmilowCancer/">Smilow Cancer Hospital</a> <a href="/YaleHemOnc/">Yale Hematology Oncology Fellows</a> meetings.asco.org/abstracts-pres…
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

What an incredible opportunity the Dixwell Community House provided chief Tendai Kwaramba, MD. MSc. to participate in the "Walk with a Doc" event as part of the Men's Health Expo and walk. Between encouraging cancer screening, mental health and learning about the community, it was a gift.

What an incredible opportunity the Dixwell Community House provided chief <a href="/KwarambaT90/">Tendai Kwaramba, MD. MSc.</a> to participate in the "Walk with a Doc" event as part of the Men's Health Expo and walk. Between encouraging cancer screening, mental health and learning about the community, it was a gift.
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

The first year fellows are almost here, and we are so thrilled. Welcome! We were feeling incomplete without you. And congratulations to our senior fellows on finishing the year strong. The future of hematology and oncology is oh so bright! ✨️

The first year fellows are almost here, and we are so thrilled. Welcome! We were feeling incomplete without you. And congratulations to our senior fellows on finishing the year strong. The future of hematology and oncology is oh so bright! ✨️
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

Congratulations to the graduates, class of 2025! You were brilliant. You were kind. You were compelling. You were inspiring. And as you go off to different parts of the country, on new and bold adventures, know that we are so proud! And know that this will always be home. 👏🏾👏🏼💙

Congratulations to the graduates, class of 2025! You were brilliant. You were kind. You were compelling. You were inspiring. And as you go off to different parts of the country, on new and bold adventures, know that we are so proud! And know that this will always be home. 👏🏾👏🏼💙